References
- Katz W A, Alexander S, Bland J H, et al. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. J Rheumatol 1982; 9(Suppl 8)173–8
- Wenger M E, Alexander S, Bland J H, Blechman W J. Auranofin versus placebo in the treatment of rheumatoid arthritis. Am J Med 1983; 75: 123–27
- Ward J A, Williams H J, Egger M J, et al. Comparison of auranofin, gold sodium thiomalate and placebo in the treatment of rheumatoid arthritis. Arthrit Rheum 1983; 26: 1303–15
- Smith P R, Brown G MM, Meyers O L. A 96-week open comparative study of auranofin versus gold sodium thiomalate in rheumatoid arthritis. Auranofin. Proceedings of a Smith Kline & French International Symposium, H A Capell, D S Cole, K K Manghani, R W Morris. Exerpta Medica, Amsterdam 1983; 181–93
- Prouse P J, Gumpel J M. Placebo-controlled comparison of auranofin with gold sodium thiomalate. Auranofin. Proceedings of a Smith Kline & French International Symposium, H A Capell, D S Cole, K K Manghani, R W Morris. Exerpta Medica, Amsterdam 1983; 303–12
- Tvede N, Strandberg B. The effect of auranofin compared with Myocrisin in the treatment of rheumatoid arthritis. Auranofin. Proceedings of a Smith Kline & French International Symposium, H A Capell, D S Cole, K K Manghani, R W Morris. Exerpta Medica, Amsterdam 1983; 442–52
- Felix-Davies D D, Stewart A M, Wilkinson B R, Bateman J R, Delamere J P. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis. Am J Med 1983; 75(6A)138–41
- Franchimont P, Hauwaert C, Marchetti M. Auranofin and D-penicillamine: a comparative assessment of safety and efficacy in patients with rheumatoid arthritis. Auranofin. Proceedings of a Smith Kline & French International Symposium, H A Capell, D S Cole, K K Manghani, R W Morris. Exerpta Medica, Amsterdam 1983; 228–39
- Manthorpe R, Horbov S, Sylvest J, Vinterberg H. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation. Scand J Rheumatol 1986; 15: 13–22
- Luthra H S, Bunch P W, O'Duffy J D, Dillon A M, Lakhanpal S, O'Fallon W M. Double-blind study comparing auranofin and D-penicillamine in rheumatoid arthritis. Scand J Rheumatol 1986, Suppl 63: 55–6
- Ropes M W, Bennett G A, Cobb S, Jacox R, Jessar R A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
- Mallya R K, Mace B EW. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. Rheum Rehab 1981; 20: 14–7
- Stein H B, Patterson A C, Offer R C, Atkins C J, Teufel A, Robinson H S. Adverse effects of D-penicillamine in rheumatoid arthritis. Ann Int Med 1980; 92: 24–9
- Blodgett R C, Pietrusko R G. Long-term efficacy and safety of auranofin: A review of clinical experience. Scand J Rheumatol 1986, Suppl 63: 67–78